Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin Effect on NPY and Sympathovagal Balance During Exercise
NCT03933787Phase 1Completed
- Start
- Jun 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Saxagliptin with Placebo (2 arms). Primary endpoint: Heart rate change variability. Started Jun 2018; status: completed.
02
Drugs
saxagliptin
Beyond the preview
Go deeper on NCT03933787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03933787.